Jutta Heix

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Jutta Heix

Feb 1, 2025, 07:49 | Blog

Vivek Subbiah: Revolutionizing Cancer Therapy - Breaking Barriers in Oncology with Tumor-Agnostic Drug Development

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…

Jan 30, 2025, 19:23 | Blog

Cancer Crosslinks 2025 on how innovations in basic research, translational research and technology can improve cancer patients' lives - Oslo Cancer Cluster

Oslo Cancer Cluster shared a post on LinkedIn: "Cancer Crosslinks 2025 put a spotlight on…

Jan 16, 2025, 22:27 | Blog

Jutta Heix: Bridging innovations to improve clinical outcomes for cancer patients

Jutta Heix, Head of International Affairs at Oslo Cancer Cluster, shared on LinkedIn: "A new…

All: 3 Posts: 1 - 100

'

Agenus and Zydus Group Announced a $141M Strategic Collaboration to Advance the Manufacturing and Global Development of BOT/BAL

'

15 Posts Not to Miss from the 4th Day of ASCO 2025

'

15 Posts Not to Miss from the 3rd Day of ASCO 2025

'

MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment

'

15 Posts Not to Miss from the 2nd Day of ASCO 2025

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023